D
Atossa Therapeutics, Inc. ATOS
$0.7775 $0.03354.50% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -0.39% 0.77% 11.38% -0.93% -13.11%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 27.23% 6.22% -20.71% -14.50% -8.83%
Operating Income -27.23% -6.22% 20.71% 14.50% 8.83%
Income Before Tax -39.25% -14.29% 18.15% -16.07% 38.46%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -39.25% -14.29% 18.15% -16.07% 38.46%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -39.25% -14.29% 18.15% -16.07% 38.46%
EBIT -27.23% -6.22% 20.71% 14.50% 8.83%
EBITDA -27.25% -6.24% 20.63% 14.52% 8.84%
EPS Basic -35.55% -10.87% 19.06% -16.16% 38.02%
Normalized Basic EPS -35.55% -10.92% 19.12% 11.33% 10.95%
EPS Diluted -35.55% -10.87% 19.06% -16.16% 38.02%
Normalized Diluted EPS -35.55% -10.92% 19.12% 11.33% 10.95%
Average Basic Shares Outstanding 2.73% 3.07% 1.05% -0.02% -0.70%
Average Diluted Shares Outstanding 2.73% 3.07% 1.05% -0.02% -0.70%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --